Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma: response to Adams and Kwee

Eldad J. Dann, Ora Paltiel

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageAmerican English
Pages (from-to)131-133
Number of pages3
JournalBritish Journal of Haematology
Volume183
Issue number1
DOIs
StatePublished - Oct 2018
Externally publishedYes

Keywords

  • Hodgkin lymphoma (HL)
  • advanced-stage Hodgkin lymphoma (advanced-HL)
  • early-stage Hodgkin lymphoma (early-HL)
  • interim PET/CT (PET-2)
  • radiation therapy (RT)

Cite this